Clinical Trial Update: Denosumab Treatment for Fibrous Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 trial update for denosumab in fibrous dysplasia under active status, focusing on bone diseases and pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Diseases
• Fibrous Dysplasia
• Pain

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Bone Diseases, Pain | Phase 2 | Status: ACTIVE_NOT_RECRUITING